Carrier screening for individuals who are pregnant or considering pregnancy and who have no family or personal history of fragile X syndrome, fragile X-related disorders (primary ovarian insufficiency, or late-onset ataxia) or unexplained intellectual disabilities, developmental delay, or autism.
Immediately following collection, mix by inverting 8 - 10 times to prevent clotting
Lavender (EDTA), 4mL x 3
Lavender (EDTA), 10mL
Yellow ACD (A or B)
Molecular Medicare billing request
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.
Ambient
Polymerase chain reaction (PCR) followed by capillary electrophoresis with reflex to Southern blot (SB) analysis for all positive samples.
An interpretive report will be provided
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.